Clinical application of autophagy proteins as prognostic biomarkers in colorectal cancer: a meta-analysis

References

• Mizushima N , LevineB, CuervoAM, KlionskyDJ. Autophagy fights disease through cellular self-digestion. Nature451(7182), 1069–1075 (2008).
   PubMed Web of Science ®Google Scholar
• Burada F , NicoliER, CiureaME, UscatuDC, IoanaM, GheoneaDI. Autophagy in colorectal cancer: an important switch from physiology to pathology. World J. Gastrointest. Oncol.7(11), 271–284 (2015).
   PubMed Web of Science ®Google Scholar
• Ma Y , GalluzziL, ZitvogelL, KroemerG. Autophagy and cellular immune responses. Immunity39(2), 211–227 (2013).
   PubMed Web of Science ®Google Scholar
• Kondo Y , KanzawaT, SawayaR, KondoS. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer5(9), 726–734 (2005).
   PubMed Web of Science ®Google Scholar
• Degenhardt K , MathewR, BeaudoinBet al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell10(1), 51–64 (2006).
   PubMed Web of Science ®Google Scholar
• Levine B , KroemerG. Autophagy in the pathogenesis of disease. Cell132(1), 27–42 (2008).
   PubMed Web of Science ®Google Scholar
• Levine B , KroemerG. Biological functions of autophagy genes: a disease perspective. Cell176(1–2), 11–42 (2019).
   PubMed Web of Science ®Google Scholar
• Ferlay J , SoerjomataramI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–386 (2015).
   PubMed Web of Science ®Google Scholar
• Brenner H , KloorM, PoxCP. Colorectal cancer. Lancet383(9927), 1490–1502 (2014).
   PubMed Web of Science ®Google Scholar
• Lièvre A , BachetJB, BoigeVet al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J. Clin. Oncol.26(3), 374–379 (2008).
   PubMed Web of Science ®Google Scholar
• Su Z , YangZ, XuY, ChenY, YuQ. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol. Cancer14, 48 (2015).
   PubMed Web of Science ®Google Scholar
• Li BX , LiCY, PengRQet al. The expression of Beclin-1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy5(3), 303–306 (2009).
   PubMed Web of Science ®Google Scholar
• Yang Z , GhoorunRA, FanXet al. High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer. Clin. Res. Hepatol. Gastroenterol.39(1), 98–106 (2015).
   PubMed Web of Science ®Google Scholar
• Han Y , XueXF, ShenHGet al. Prognostic significance of Beclin-1 expression in colorectal cancer: a meta-analysis. Asian Pac. J. Cancer Prev.15(11), 4583–4587 (2014).
   PubMedGoogle Scholar
• Park JM , HuangS, WuTT, FosterNR, SinicropeFA. Prognostic impact of Beclin-1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol. Ther.14(2), 100–107 (2013).
   PubMed Web of Science ®Google Scholar
• Wu S , SunC, TianDet al. Expression and clinical significances of Beclin-1, LC3 and mTOR in colorectal cancer. Int. J. Clin. Exp. Pathol.8(4), 3882–3891 (2015).
   PubMed Web of Science ®Google Scholar
• Yang M , ZhaoH, GuoLet al. Autophagy-based survival prognosis in human colorectal carcinoma. Oncotarget6(9), 7084–7103 (2015).
   PubMedGoogle Scholar
• Page MJ , McKenzieJE, BossuytPMet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372(2021). PMID:8005924 doi:10.1136/bmj.n71
   Google Scholar
• Cumpston M , LiT, PageMJet al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev.10, Ed000142 (2019).
   PubMed Web of Science ®Google Scholar
• Guo GF , WangYX, ZhangYJet al. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: analysis from real-world data. World J. Gastroenterol.25(15), 1840–1853 (2019).
   PubMed Web of Science ®Google Scholar
• Koukourakis MI , GiatromanolakiA, SivridisE, PitiakoudisM, GatterKC, HarrisAL. Beclin-1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br. J. Cancer103(8), 1209–1214 (2010).
   PubMed Web of Science ®Google Scholar
• Koustas E , SarantisP, TheoharisSet al. Autophagy-related proteins as a prognostic factor of patients with colorectal cancer. Am. J. Clin. Oncol.42(10), 767–776 (2019).
   PubMed Web of Science ®Google Scholar
• Schmitz KJ , AdemiC, BertramS, SchmidKW, BabaHA. Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status. World J. Surg. Oncol.14(1), 189 (2016).
   PubMedGoogle Scholar
• Shim BY , SunS, WonHSet al. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy. BMC Cancer16, 207 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang MY , GouWF, ZhaoSet al. Beclin-1 expression is closely linked to colorectal carcinogenesis and distant metastasis of colorectal carcinoma. Int. J. Mol. Sci.15(8), 14372–14385 (2014).
   PubMed Web of Science ®Google Scholar
• Haruki K , KosumiK, HamadaTet al. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. J. Pathol.250(4), 397–408 (2020).
   PubMed Web of Science ®Google Scholar
• Choi JH , ChoYS, KoYH, HongSU, ParkJH, LeeMA. Absence of autophagy-related proteins expression is associated with poor prognosis in patients with colorectal adenocarcinoma. Gastroenterol. Res. Pract.2014, 179586 (2014).
   PubMed Web of Science ®Google Scholar
• Guo GF , JiangWQ, ZhangBet al. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J. Gastroenterol.17(43), 4779–4786 (2011).
   PubMed Web of Science ®Google Scholar
• Wu S , SunC, TianDet al. Expression of Beclin-1, LC3 and mTOR and their significance in colorectal carcinoma. Int. J. Clin. Exp. Pathol.8(4), 3882–3891 (2014).
   Web of Science ®Google Scholar
• Niklaus M , AdamsO, BerezowskaSet al. Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer. Oncotarget8(33), 54604–54615 (2017).
   PubMedGoogle Scholar
• Wang Y , ZhaoZ, ZhuangJet al. Prognostic value of autophagy, microsatellite instability, and KRAS mutations in colorectal cancer. J. Cancer12(12), 3515–3528 (2021).
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A , KoukourakisMI, HarrisAL, PolychronidisA, GatterKC, SivridisE. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J. Clin. Pathol.63(10), 867–872 (2010).
   PubMed Web of Science ®Google Scholar
• Lei C , ZhaoB, LiuL, ZengX, YuZ, WangX. Expression and clinical significance of p62 protein in colon cancer. Medicine (Baltimore)99(3), e18791 (2020).
   PubMed Web of Science ®Google Scholar
• Jo YK , KimSC, ParkIJet al. Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis. PLOS ONE7(12), e52705 (2012).
   PubMed Web of Science ®Google Scholar
• Zou Y , ChenZ, HeXet al. High expression levels of unc-51-like kinase 1 as a predictor of poor prognosis in colorectal cancer. Oncol. Lett.10(3), 1583–1588 (2015).
   PubMed Web of Science ®Google Scholar
• Panda PK , MukhopadhyayS, DasDN, SinhaN, NaikPP, BhutiaSK. Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics. Semin. Cell Dev. Biol.39, 43–55 (2015).
   PubMed Web of Science ®Google Scholar
• Green DR , GalluzziL, KroemerG. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science333(6046), 1109–1112 (2011).
   PubMed Web of Science ®Google Scholar
• Weiner LM , LotzeMT. Tumor-cell death, autophagy, and immunity. N. Engl. J. Med.366(12), 1156–1158 (2012).
   PubMed Web of Science ®Google Scholar
• Mathew R , KongaraS, BeaudoinBet al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev.21(11), 1367–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Mathew R , Karantza-WadsworthV, WhiteE. Role of autophagy in cancer. Nat. Rev. Cancer7(12), 961–967 (2007).
   PubMed Web of Science ®Google Scholar
• Aita VM , LiangXH, MurtyVVet al. Cloning and genomic organization of Beclin-1, a candidate tumor suppressor gene on chromosome 17q21. Genomics59(1), 59–65 (1999).
   PubMed Web of Science ®Google Scholar
• He Y , ZhaoX, SubahanNR, FanL, GaoJ, ChenH. The prognostic value of autophagy-related markers Beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol.35(8), 7317–7326 (2014).
   PubMedGoogle Scholar
• Li J , HouN, FariedA, TsutsumiS, KuwanoH. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur. J. Cancer46(10), 1900–1909 (2010).
   PubMed Web of Science ®Google Scholar
• Apel A , HerrI, SchwarzH, RodemannHP, MayerA. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res.68(5), 1485–1494 (2008).
   PubMed Web of Science ®Google Scholar
• Guo XL , LiD, HuFet al. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett.320(2), 171–179 (2012).
   PubMed Web of Science ®Google Scholar
• Schläfli AM , BerezowskaS, AdamsO, LangerR, TschanMP. Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry. Eur. J. Histochem.59(2), 2481 (2015).
   PubMed Web of Science ®Google Scholar
• Liu WJ , YeL, HuangWFet al. p62 links the autophagy pathway and the ubiquitin-proteasome system upon ubiquitinated protein degradation. Cell Mol. Biol. Lett.21, 29 (2016).
   PubMed Web of Science ®Google Scholar
• Kobayashi T , IshidaM, MikiHet al. p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study. Colorectal Dis.23(5), 1083–1090 (2021).
   PubMed Web of Science ®Google Scholar
• Zhao H , YangM, ZhaoB. Beclin-1 and LC3 as predictive biomarkers for metastatic colorectal carcinoma. Oncotarget8(35), 59058–59067 (2017).
   PubMedGoogle Scholar
• Dong Y , WuY, ZhaoGL, YeZY, XingCG, YangXD. Inhibition of autophagy by 3-MA promotes hypoxia-induced apoptosis in human colorectal cancer cells. Eur. Rev. Med. Pharm. Sci.23(3), 1047–1054 (2019).
   PubMed Web of Science ®Google Scholar
• Li J , HouN, FariedA, TsutsumiS, TakeuchiT, KuwanoH. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann. Surg. Oncol.16(3), 761–771 (2009).
   PubMed Web of Science ®Google Scholar